Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Apr 1;339(Pt 1):21–32.

Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

M F Vickers 1, R S Mani 1, M Sundaram 1, D L Hogue 1, J D Young 1, S A Baldwin 1, C E Cass 1
PMCID: PMC1220123  PMID: 10085223

Abstract

We have produced recombinant human equilibrative nucleoside transporter (hENT1) in the yeast Saccharomyces cerevisiae and have compared the binding of inhibitors of equilibrative nucleoside transport with the wild-type transporter and a N-glycosylation-defective mutant transporter. Equilibrium binding of 3H-labelled nitrobenzylmercaptopurine ribonucleoside ¿6-[(4-nitrobenzyl)thio]-9-beta-d-ribofuranosyl purine; NBMPR¿ to hENT1-producing yeast revealed a single class of high-affinity sites that were shown to be in membrane fractions by (1) equilibrium binding (means+/-S.D.) of [3H]NBMPR to intact yeast (Kd 1.2+/-0.2 nM; Bmax 5.0+/-0.5 pmol/mg of protein) and membranes (Kd 0.7+/-0.2 nM; Bmax 6.5+/-1 pmol/mg of protein), and (2) reconstitution of hENT1-mediated [3H]thymidine transport into proteoliposomes that was potently inhibited by NBMPR. Dilazep and dipyridamole inhibited NBMPR binding to hENT1 with IC50 values of 130+/-10 and 380+/-20 nM respectively. The role of N-linked glycosylation in the interaction of NBMPR with hENT1 was examined by the quantification of binding of [3H]NBMPR to yeast producing either wild-type hENT1 or a glycosylation-defective mutant (hENT1/N48Q) in which Asn-48 was converted into Gln. The Kd for binding of NBMPR to hENT1/N48Q was 10. 5+/-1.6 nM, indicating that the replacement of an Asn residue with Gln decreased the affinity of hENT1 for NBMPR. The decreased affinity of hENT1/N48Q for NBMPR was due to an increased rate of dissociation (koff) and a decreased rate of association (kon) of specifically bound [3H]NBMPR because the values for hENT1-producing and hENT1/N48Q-producing yeast were respectively 0.14+/-0.02 and 0. 36+/-0.05 min-1 for koff, and (1.2+/-0.1)x10(8) and (0.40+/-0. 04)x10(8) M-1.min-1 for kon. These results indicated that the conservative conversion of an Asn residue into Gln at position 48 of hENT1 and/or the loss of N-linked glycosylation capability altered the binding characteristics of the transporter for NBMPR, dilazep and dipyridamole.

Full Text

The Full Text of this article is available as a PDF (265.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agbanyo F. R., Cass C. E., Paterson A. R. External location of sites on pig erythrocyte membranes that bind nitrobenzylthioinosine. Mol Pharmacol. 1988 Mar;33(3):332–337. [PubMed] [Google Scholar]
  2. Boleti H., Coe I. R., Baldwin S. A., Young J. D., Cass C. E. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells. Neuropharmacology. 1997 Sep;36(9):1167–1179. doi: 10.1016/s0028-3908(97)00136-6. [DOI] [PubMed] [Google Scholar]
  3. Boumah C. E., Hogue D. L., Cass C. E. Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells. Biochem J. 1992 Dec 15;288(Pt 3):987–996. doi: 10.1042/bj2880987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cass C. E., Paterson A. R. Nitrobenzylthionionosine binding sites in the erythrocyte membrane. Biochim Biophys Acta. 1976 Jan 21;419(2):285–294. doi: 10.1016/0005-2736(76)90354-0. [DOI] [PubMed] [Google Scholar]
  5. Che M., Ortiz D. F., Arias I. M. Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na(+)-nucleoside cotransporter. J Biol Chem. 1995 Jun 9;270(23):13596–13599. doi: 10.1074/jbc.270.23.13596. [DOI] [PubMed] [Google Scholar]
  6. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  7. Crawford C. R., Ng C. Y., Ullman B., Belt J. A. Identification and reconstitution of the nucleoside transporter of CEM human leukemia cells. Biochim Biophys Acta. 1990 May 24;1024(2):289–297. doi: 10.1016/0005-2736(90)90357-t. [DOI] [PubMed] [Google Scholar]
  8. Crawford C. R., Patel D. H., Naeve C., Belt J. A. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J Biol Chem. 1998 Feb 27;273(9):5288–5293. doi: 10.1074/jbc.273.9.5288. [DOI] [PubMed] [Google Scholar]
  9. Griffith D. A., Jarvis S. M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta. 1996 Oct 29;1286(3):153–181. doi: 10.1016/s0304-4157(96)00008-1. [DOI] [PubMed] [Google Scholar]
  10. Griffiths M., Beaumont N., Yao S. Y., Sundaram M., Boumah C. E., Davies A., Kwong F. Y., Coe I., Cass C. E., Young J. D. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med. 1997 Jan;3(1):89–93. doi: 10.1038/nm0197-89. [DOI] [PubMed] [Google Scholar]
  11. Griffiths M., Yao S. Y., Abidi F., Phillips S. E., Cass C. E., Young J. D., Baldwin S. A. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J. 1997 Dec 15;328(Pt 3):739–743. doi: 10.1042/bj3280739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hammond J. R. Functional reconstitution of pharmacologically distinct subtypes of nucleoside transporters in liposomal membranes. J Pharmacol Exp Ther. 1994 Nov;271(2):906–917. [PubMed] [Google Scholar]
  13. Hammond J. R. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site. Mol Pharmacol. 1991 Jun;39(6):771–779. [PubMed] [Google Scholar]
  14. Hammond J. R., Zarenda M. Effect of detergents on ligand binding and translocation activities of solubilized/reconstituted nucleoside transporters. Arch Biochem Biophys. 1996 Aug 15;332(2):313–322. doi: 10.1006/abbi.1996.0347. [DOI] [PubMed] [Google Scholar]
  15. Harley E. R., Paterson A. R., Cass C. E. Initial rate kinetics of the transport of adenosine and 4-amino-7-(beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine (tubercidin) in cultured cells. Cancer Res. 1982 Apr;42(4):1289–1295. [PubMed] [Google Scholar]
  16. Hogue D. L., Ellison M. J., Vickers M., Cass C. E. Functional complementation of a membrane transport deficiency in Saccharomyces cerevisiae by recombinant ND4 fusion protein. Biochem Biophys Res Commun. 1997 Sep 29;238(3):811–816. doi: 10.1006/bbrc.1997.7400. [DOI] [PubMed] [Google Scholar]
  17. Hogue D. L., Ellison M. J., Young J. D., Cass C. E. Identification of a novel membrane transporter associated with intracellular membranes by phenotypic complementation in the yeast Saccharomyces cerevisiae. J Biol Chem. 1996 Apr 19;271(16):9801–9808. doi: 10.1074/jbc.271.16.9801. [DOI] [PubMed] [Google Scholar]
  18. Hogue D. L., Hodgson K. C., Cass C. E. Effects of inhibition of N-linked glycosylation by tunicamycin on nucleoside transport polypeptides of L1210 leukemia cells. Biochem Cell Biol. 1990 Jan;68(1):199–209. doi: 10.1139/o90-026. [DOI] [PubMed] [Google Scholar]
  19. Huang Q. Q., Yao S. Y., Ritzel M. W., Paterson A. R., Cass C. E., Young J. D. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem. 1994 Jul 8;269(27):17757–17760. [PubMed] [Google Scholar]
  20. Ito H., Fukuda Y., Murata K., Kimura A. Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 1983 Jan;153(1):163–168. doi: 10.1128/jb.153.1.163-168.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jarvis S. M., Janmohamed S. N., Young J. D. Kinetics of nitrobenzylthioinosine binding to the human erythrocyte nucleoside transporter. Biochem J. 1983 Dec 15;216(3):661–667. doi: 10.1042/bj2160661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jarvis S. M., McBride D., Young J. D. Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites. J Physiol. 1982 Mar;324:31–46. doi: 10.1113/jphysiol.1982.sp014099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jarvis S. M. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole. Mol Pharmacol. 1986 Dec;30(6):659–665. [PubMed] [Google Scholar]
  24. Jarvis S. M., Young J. D. Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites. Biochem J. 1980 Aug 15;190(2):377–383. doi: 10.1042/bj1900377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kaiser B. N., Finnegan P. M., Tyerman S. D., Whitehead L. F., Bergersen F. J., Day D. A., Udvardi M. K. Characterization of an ammonium transport protein from the peribacteroid membrane of soybean nodules. Science. 1998 Aug 21;281(5380):1202–1206. doi: 10.1126/science.281.5380.1202. [DOI] [PubMed] [Google Scholar]
  26. Koren R., Cass C. E., Paterson A. R. The kinetics of dissociation of the inhibitor of nucleoside transport, nitrobenzylthioinosine, from the high-affinity binding sites of cultured hamster cells. Biochem J. 1983 Nov 15;216(2):299–308. doi: 10.1042/bj2160299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol. 1991 Nov;115(4):887–903. doi: 10.1083/jcb.115.4.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986 Jan 31;44(2):283–292. doi: 10.1016/0092-8674(86)90762-2. [DOI] [PubMed] [Google Scholar]
  29. Kwong F. Y., Baldwin S. A., Scudder P. R., Jarvis S. M., Choy M. Y., Young J. D. Erythrocyte nucleoside and sugar transport. Endo-beta-galactosidase and endoglycosidase-F digestion of partially purified human and pig transporter proteins. Biochem J. 1986 Dec 1;240(2):349–356. doi: 10.1042/bj2400349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kwong F. Y., Davies A., Tse C. M., Young J. D., Henderson P. J., Baldwin S. A. Purification of the human erythrocyte nucleoside transporter by immunoaffinity chromatography. Biochem J. 1988 Oct 1;255(1):243–249. [PMC free article] [PubMed] [Google Scholar]
  31. Kwong F. Y., Wu J. S., Shi M. M., Fincham H. E., Davies A., Henderson P. J., Baldwin S. A., Young J. D. Enzymic cleavage as a probe of the molecular structures of mammalian equilibrative nucleoside transporters. J Biol Chem. 1993 Oct 15;268(29):22127–22134. [PubMed] [Google Scholar]
  32. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  33. Mackey J. R., Baldwin S. A., Young J. D., Cass C. E. Nucleoside transport and its significance for anticancer drug resistance. Drug Resist Updat. 1998;1(5):310–324. doi: 10.1016/s1368-7646(98)80047-2. [DOI] [PubMed] [Google Scholar]
  34. Mahanty S. K., Rao U. S., Nicholas R. A., Scarborough G. A. High yield expression of the Neurospora crassa plasma membrane H(+)-ATPase in Saccharomyces cerevisiae. J Biol Chem. 1994 Jul 1;269(26):17705–17712. [PubMed] [Google Scholar]
  35. Mani R. S., Hammond J. R., Marjan J. M., Graham K. A., Young J. D., Baldwin S. A., Cass C. E. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes. J Biol Chem. 1998 Nov 13;273(46):30818–30825. doi: 10.1074/jbc.273.46.30818. [DOI] [PubMed] [Google Scholar]
  36. Ritzel M. W., Yao S. Y., Huang M. Y., Elliott J. F., Cass C. E., Young J. D. Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). Am J Physiol. 1997 Feb;272(2 Pt 1):C707–C714. doi: 10.1152/ajpcell.1997.272.2.C707. [DOI] [PubMed] [Google Scholar]
  37. Ritzel M. W., Yao S. Y., Ng A. M., Mackey J. R., Cass C. E., Young J. D. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol. 1998 Oct-Dec;15(4):203–211. doi: 10.3109/09687689709044322. [DOI] [PubMed] [Google Scholar]
  38. Ruetz S., Gros P. Functional expression of P-glycoproteins in secretory vesicles. J Biol Chem. 1994 Apr 22;269(16):12277–12284. [PubMed] [Google Scholar]
  39. Sekler I., Kopito R., Casey J. R. High level expression, partial purification, and functional reconstitution of the human AE1 anion exchanger in Saccharomyces cerevisiae. J Biol Chem. 1995 Sep 8;270(36):21028–21034. doi: 10.1074/jbc.270.36.21028. [DOI] [PubMed] [Google Scholar]
  40. Sundaram M., Yao S. Y., Ng A. M., Griffiths M., Cass C. E., Baldwin S. A., Young J. D. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem. 1998 Aug 21;273(34):21519–21525. doi: 10.1074/jbc.273.34.21519. [DOI] [PubMed] [Google Scholar]
  41. Tse C. M., Belt J. A., Jarvis S. M., Paterson A. R., Wu J. S., Young J. D. Reconstitution studies of the human erythrocyte nucleoside transporter. J Biol Chem. 1985 Mar 25;260(6):3506–3511. [PubMed] [Google Scholar]
  42. Wang J., Su S. F., Dresser M. J., Schaner M. E., Washington C. B., Giacomini K. M. Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am J Physiol. 1997 Dec;273(6 Pt 2):F1058–F1065. doi: 10.1152/ajprenal.1997.273.6.F1058. [DOI] [PubMed] [Google Scholar]
  43. Yao S. Y., Ng A. M., Muzyka W. R., Griffiths M., Cass C. E., Baldwin S. A., Young J. D. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem. 1997 Nov 7;272(45):28423–28430. doi: 10.1074/jbc.272.45.28423. [DOI] [PubMed] [Google Scholar]
  44. Yao S. Y., Ng A. M., Ritzel M. W., Gati W. P., Cass C. E., Young J. D. Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes. Mol Pharmacol. 1996 Dec;50(6):1529–1535. [PubMed] [Google Scholar]
  45. Zinser E., Daum G. Isolation and biochemical characterization of organelles from the yeast, Saccharomyces cerevisiae. Yeast. 1995 May;11(6):493–536. doi: 10.1002/yea.320110602. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES